Anastrozole Tablet, Coated
Product Images NDC 68382-209

This appears to be a chart or graph with the title "Proportion alive and disease-free". The horizontal axis represents "disease-free survival in months" and the vertical axis appears to represent the proportion of patients who are alive and disease-free. There are two treatment options being compared, but the names are not entirely legible due to inaccuracies. It appears one treatment option may be "tamodfen" or "tamoten" and the other option may be "anastrozole". The chart includes data points for each treatment option at various intervals of disease-free survival, possibly indicating the proportion of patients on each treatment who remain alive and disease-free after that amount of time.*

This table is showing the comparison of disease-free survival in months between two randomized treatments. The treatments are mentioned as anastrozole and anasromole. At the bottom, the number of patients at risk is given. *

This appears to be a graph or chart of a medical study comparing randomized treatment using anastrozole and tamoxifen. The x-axis measures time to event in months, while the y-axis is labeled "PROPORTION EVENT FREE" with values ranging from 0 to 1. The chart shows two lines representing the two treatments that converge and diverge over time. There is also a note at the bottom explaining that the vertical axis has been truncated to improve the clarity of the graph.*

The text is a graph showing the proportion of event-free patients over time (in months) for a randomized treatment with anastrozole and tamoxifen. The number of patients at risk is also provided. The vertical axis has been truncated for clarity.*

This appears to be a graph showing the time to progression of randomized treatments (Anastrozole and Tamoxifen) over a certain period of months. The number of patients at risk for each treatment is also provided.*

The text describes a graph that shows the time to progression in months for randomized treatments, Anastrolze and Tamoxifen. However, the proportion is not progressing.*

This is a product description for Anastrozole B tablets. The tablets are USP controlled and come in a container that is resistant to dipersing and resistntand. The recommended storage temperature is between 25- 68" 77°F. The product is manufactured by Codls Hearars 1. Fid Bemacie, gz and distributed by 1,000 TABLETS et USA at 7t 2ydus Reony rosgm gt. The product label warns to keep all drugs out of reach of children.*